FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Balaji Speciality Chemicals IPO and Concord Biotech IPO.
Balaji Speciality Chemicals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Concord Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Balaji Speciality Chemicals IPO | Concord Biotech IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Hdfc Bank Limited Jm Financial Limited |
Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL |
The total issue size of Balaji Speciality Chemicals IPO is whereas the issue size of the Concord Biotech IPO is up to ₹1,551.00 Cr. The final issue price of Balaji Speciality Chemicals IPO is and of Concord Biotech IPO is ₹741.00 per share.
Balaji Speciality Chemicals IPO | Concord Biotech IPO | |
---|---|---|
Face Value | ₹2 per share | ₹1 per share |
Issue Price (Lower) | ₹705.00 per share | |
Issue Price (Upper) | ₹741.00 per share | |
Issue Price (Final) | ₹741.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ₹70.00 per share | |
Market Lot Size | 20 shares | |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹250.00 Cr | |
OFS Issue Size | 2,60,00,000 shares | 2,09,25,652 shares |
OFS Issue Size (Amount) | up to ₹1,551.00 Cr | |
Issue Size Total | 2,09,25,652 shares | |
Issue Size Total (Amount) | up to ₹1,551.00 Cr |
Balaji Speciality Chemicals IPO opens on , while Concord Biotech IPO opens on Aug 04, 2023. The closing date of Balaji Speciality Chemicals IPO and Concord Biotech IPO is , and Aug 08, 2023, respectively.
Balaji Speciality Chemicals IPO | Concord Biotech IPO | |
---|---|---|
Anchor Bid Date | Aug 03, 2023 | |
Issue Open | Aug 04, 2023 | |
Issue Close | Aug 08, 2023 | |
Basis Of Allotment (Tentative) | Aug 11, 2023 | |
Initiation of Refunds (Tentative) | Aug 14, 2023 | |
Credit of Share (Tentative) | Aug 17, 2023 | |
Listing date (Tentative) | Aug 18, 2023 | |
Anchor Lockin End date 1 | Sep 10, 2023 | |
Anchor Lockin End date 2 | Nov 09, 2023 |
Balaji Speciality Chemicals IPO P/E ratio is , as compared to Concord Biotech IPO P/E ratio of 32.29.
Balaji Speciality Chemicals IPO | Concord Biotech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Crore |
Amount in ₹ Crore |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 97.98% | 44.08% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 44.08% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 32.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹7752.06 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 20.06%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 24.27%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹20.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 20%% |
In the Balaji Speciality Chemicals IPO retail investors (RII) are offered while in Concord Biotech IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Balaji Speciality Chemicals IPO and 41,83,130 shares in Concord Biotech IPO.
Balaji Speciality Chemicals IPO | Concord Biotech IPO | |
---|---|---|
Anchor Investor Reserveration | 62,74,695 shares | |
Market Maker Reserveration | ||
QIB | 41,83,130 shares | |
NII | 31,37,348 shares | |
RII | 73,20,479 shares | |
Employee | 10,000 shares | |
Others | ||
Total | 1,46,50,957 shares |
Balaji Speciality Chemicals IPO subscribed in total, whereas Concord Biotech IPO subscribed 24.87x.
Balaji Speciality Chemicals IPO | Concord Biotech IPO | |
---|---|---|
QIB (times) | 67.67x | |
NII (times) | 16.99x | |
Big NII (times) | 19.30x | |
Small NII (times) | 12.37x | |
RII (times) | 3.78x | |
Employee (times) | 24.48x | |
Other (times) | ||
Total (times) | 24.87x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|